LPCAT4 and hepatocellular carcinoma: LPCAT4 activates the WNT-β-catenin pathway in cancer cells, leading to increased cholesterol synthesis, which suggests that LPCAT4 may be a therapeutic target for the treatment of hepatocellular carcinoma.